RNS Number: 6021 B Vectura Group plc 10 June 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. VECTURA GROUP PLC ANNOUNCES LEADERSHIP CHANGES. Chippenham, UK- 10 June 2019: Vectura Group plc today announces that James Ward-Lilley will be stepping down from the Board and his position as Chief Executive Officer on 30 th June 2019.
RNS Number: 8459 A Vectura Group plc 03 June 2019. Vectura Group plc notifies that the Company's issued share capital as at 31 May 2019 consisted of 666,304,286 ordinary shares, and 34,000 preference shares with no voting rights. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7508 A Vectura Group plc 31 May 2019. Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Vectura Group plc confirms that on 30 May 2019, the Trustee informed the Company of an award of Free Shares under the Vectura Group plc Share Incentive Plan 2006 to...
RNS Number: 4982 A Vectura Group plc 29 May 2019. Results of the Vectura Annual General Meeting. Chippenham, UK, 29 May 2019: Vectura Group plc, announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed on a poll, the results of which are set out below:.
RNS Number: 3919 A Vectura Group plc 29 May 2019. Chippenham, UK- 29 May 2019: Vectura Group plc, provides a trading update ahead of its Annual General Meeting being held today at 10.30 am at the offices of Clifford Chance LLP, 10 Upper Bank Street, London E14 5 JJ.. Based on overall trading performance to date in 2019, the Board confirms the outlook remains in line with...
RNS Number: 0548 A Vectura Group plc 24 May 2019. Vectura receives $2.5 m milestone payment for the European regulatory submission of QVM149. Chippenham, UK- 24 May 2019: Vectura Group plc, announced today that it will receive a $2.5 million milestone payment under an exclusive licence agreement with Novartis AG.
RNS Number: 7097 Z Vectura Group plc 21 May 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Vectura wins US GSK patent litigation and awarded $89.7 million in damages by trial jury. Chippenham, UK- 07 May 2019: Vectura Group plc confirms that on 3rd May 2019 following a jury trial in the United States District Court for the District of Delaware, the relevant asserted claim of Vectura's US patent 8303991 was found valid and infringed by US sales of three of...
RNS Number: 6452 X Vectura Group plc 01 May 2019. Vectura Group plc notifies that the Company's issued share capital as at 30 April 2019 consisted of 665,576,371 ordinary shares, and 34,000 preference shares with no voting rights. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2647 X Vectura Group plc 26 April 2019. Chippenham, UK, 26 April 2019: Vectura Group plc confirms that on 25 April 2019, the following Persons Discharging Managerial responsibility were granted Share Awards over ordinary shares of 0.025 pence each in Vectura Group plc under the Vectura 2015 Long Term Incentive Plan, as set out below:.
RNS Number: 2635 X Vectura Group plc 26 April 2019. Chippenham, UK, 26 April 2019: Vectura Group plc confirms that on 25 April 2019, the following Persons Discharging Managerial responsibility were granted Share Awards over ordinary shares of 0.025 pence each in Vectura Group plc under the Vectura 2015 Long Term Incentive Plan, as set out below:.
RNS Number: 6776 W Vectura Group plc 18 April 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3772 W Vectura Group plc 16 April 2019 Vectura Group plc. Chippenham, UK- 16 April 2019: Vectura Group plc announces that today it has released the following documents:. The AGM is scheduled to be held at 10.30 on Wednesday 29 May 2019 at the offices of Clifford Chance LLP, 10 Upper Bank Street, London E14 5 JJ.
RNS Number: 6682 U Vectura Group plc 01 April 2019. Vectura Group plc notifies that the Company's issued share capital as at 31 March 2019 consisted of 665,387,145 ordinary shares, and 34,000 preference shares with no voting rights. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6698 U Vectura Group plc 01 April 2019. Name of applicant: Vectura Group plc. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6528 U Vectura Group plc 01 April 2019. Vectura Group appoints Kevin Matthews to its Board of Directors. Chippenham, UK- 1 April 2019: Vectura Group plc, an industry-leading inhaled product formulation, device design and development business, is pleased to announce the appointment of Dr Kevin Matthews as an Independent Non-Executive Director of the...
Chippenham, UK- 26 March 2019: Vectura Group plc today announces its preliminary results for the year ended 31 December 2018. o Strong flutiform ® performance with Vectura revenues of £79.6 m, +13.7%, driven by strong product supply revenues,+ 17.0%. ·Adjusted EBITDA of £39.0 m, up 51.2%, driven by revenue growth, improved gross margin, lower R&D costs and...
RNS Number: 5844 R Vectura Group plc 01 March 2019. Vectura Group plc notifies that the Company's issued share capital as at 28 February 2019 consisted of 665,387,145 ordinary shares, and 34,000 preference shares with no voting rights. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8293 O Vectura Group plc 01 February 2019 VECTURA GROUP PLC. Vectura Group plc notifies that the Company's issued share capital as at 31 January 2019 consisted of 665,387,145 ordinary shares, and 34,000 preference shares with no voting rights. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United...
RNS Number: 4222 M Vectura Group plc 07 January 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Vectura Group Plc
VEC.L
Vectura Group Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    665.39M

Company Profile

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Classification

Market Indices-

Locations

HQ
1 Prospect West
Chippenham
SN14 6FH
Watchlist